Testing a new drug after chemo for advanced pancreatic cancer
Part of Cancer clinical trials.
This study tests an investigational drug (RR001) given after chemotherapy for people with locally advanced pancreatic cancer that hasn't spread. It aims to see if the new treatment is safe and may help shrink tumors that can be reached with a needle injection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of pancreatic cancer called adenocarcinoma that has not spread to other organs.
- At least one of your tumors is 3.5 cm or smaller and can be reached with a needle for an injection.
- You have not had radiation or chemotherapy for this cancer before.
- You must be in fairly good health to receive standard chemotherapy treatment.
- Your blood tests and organ functions (liver, kidneys) need to be normal enough for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to deliver a drug called amifostine (XER-001) alongside intense radiation therapy (SBRT) for people with locally advanced pancreatic cancer that can't be surgically removed. The goal is to see if it's safe and effective at protecting healthy tissue while targeting the tumor.
This trial tests a special, high-dose radiation treatment for pancreatic cancer that has not spread but cannot be removed with surgery. The goal is to shrink the tumor and improve control of the cancer in the abdomen.
This trial tests a new treatment that uses tiny alpha radiation sources placed directly into the tumor to destroy cancer cells. It is for people with pancreatic cancer that has not spread but cannot be removed surgically, and who have already tried at least one type of chemotherapy or cannot take more chemo.
This trial tests a new injectable treatment (NRT6008) given with standard chemotherapy for people whose pancreatic cancer cannot be removed by surgery. The goal is to see if it helps control the tumor better than chemo alone.
This trial tests a new drug, MR001, combined with chemotherapy for people whose pancreatic cancer has spread and no longer responds to their first treatment. It aims to see if this combination can help shrink tumors or slow the disease.
This trial tests a new drug for people with advanced pancreatic cancer that has grown despite at least one prior chemotherapy. The goal is to see if this drug can shrink tumors or slow the cancer, potentially giving patients more time.
Hear when a new Locally Advanced Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.